Research Article
BibTex RIS Cite

Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs

Year 1991, Volume: 4 Issue: 2, 51 - 56, 01.04.1991

N. Çiftçi S. Küllü Ö. Aktan

Abstract

The hepatic protective effect of intravenous verapamil in dogs (n=8) during halothane anesthesia in hypoxic conditions was observed. The protective potential was defined by both histopatholu^ a! evaluation and serum en/.yme level measurements. Mean alkaline phosphatase and lactic dehydrogenase enzyme levels in the group administered with calcium channel blocker-verapamil were noted,although not statistically significant, to be lower than those of the control group.

Further prcnchymal injury during histopathological evaluation using the light microscope were noted to be significantly less in the verapamil group administered when compared to the control group.

Keywords

Calcium channel blockers: verapamil Liver: hepatoprotectivity Anesthetics inhalational: halothane Hypoxia Damage: hepatic

Year 1991, Volume: 4 Issue: 2, 51 - 56, 01.04.1991

N. Çiftçi S. Küllü Ö. Aktan

Abstract

There are 0 citations in total.

Details

Subjects Clinical Sciences
Journal Section Articles
Authors

N. Çiftçi This is me

S. Küllü This is me

Ö. Aktan This is me

Publication Date April 1, 1991
Published in Issue Year 1991 Volume: 4 Issue: 2

Cite

APA Çiftçi, N., Küllü, S., & Aktan, Ö. (1991). Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs. Marmara Medical Journal, 4(2), 51-56.
AMA Çiftçi N, Küllü S, Aktan Ö. Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs. Marmara Med J. April 1991;4(2):51-56.
Chicago Çiftçi, N., S. Küllü, and Ö. Aktan. “Invivo Hepatoprotectivity of Intravenous Verapamil During Hypoxic Halothane Anaesthesia in Dogs”. Marmara Medical Journal 4, no. 2 (April 1991): 51-56.
EndNote Çiftçi N, Küllü S, Aktan Ö (April 1, 1991) Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs. Marmara Medical Journal 4 2 51–56.
IEEE N. Çiftçi, S. Küllü, and Ö. Aktan, “Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs”, Marmara Med J, vol. 4, no. 2, pp. 51–56, 1991.
ISNAD Çiftçi, N. et al. “Invivo Hepatoprotectivity of Intravenous Verapamil During Hypoxic Halothane Anaesthesia in Dogs”. Marmara Medical Journal 4/2 (April 1991), 51-56.
JAMA Çiftçi N, Küllü S, Aktan Ö. Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs. Marmara Med J. 1991;4:51–56.
MLA Çiftçi, N. et al. “Invivo Hepatoprotectivity of Intravenous Verapamil During Hypoxic Halothane Anaesthesia in Dogs”. Marmara Medical Journal, vol. 4, no. 2, 1991, pp. 51-56.
Vancouver Çiftçi N, Küllü S, Aktan Ö. Invivo hepatoprotectivity of intravenous verapamil during hypoxic halothane anaesthesia in dogs. Marmara Med J. 1991;4(2):51-6.